
What’s the Prognosis for Children with Localized Scleroderma?
Most children and teens with localized scleroderma who start treatment early have a good prognosis. They’re fully able to engage in their normal daily activities, like school, self-care, sports, or play. The outlook for children and teens with LS has greatly improved since 2000 because of great strides made in diagnosis and treatments.
Recent studies show that now, due to advances in care by pediatric rheumatologists, children with jLS are far less likely to have severe function setbacks or a need for major surgery now than in the past:
We won’t stop working to improve the lives of children and teens with this disease.
Some studies suggest that between 15-50% of children with localized scleroderma may have a relapse or recurrence of disease after treatment. In one key study, earlier treatment was associated with lower risk for relapse.

No two scleroderma journeys are the same, but there are common experiences along the way. No matter where you, your child, or a loved one are in your journey, or the type of scleroderma, the National Scleroderma Foundation can help you find your best path.